Betaine

DB06756ApprovedInvestigationalNutraceuticalSmall moleculeGastrointestinal AgentsMethylating Agent

Betaine is a methyl group donor used for the treatment of homocystinuria to decrease elevated homocysteine blood levels. Betaine is a methyl group donor that functions in the normal metabolic cycle of methionine.

Chemical structure of Betaine
Mechanism
Curator reviewed · 6 references
Primary indication
Betaine is indicated for the treatment of homocystinuria in pediatric and adult patients to decrease elevated homocysteine blood levels.Curator reviewed · 4 structured indications
Formula / weight
C5H11NO2 · 117.1463 g/mol (avg)
First approval
Canada, 2018 · United States, 1996 · European Union, 2016
Also known as
2-trimethylammonioacetate · Abromine · Acidol · Glycine betaine · Glycinebetaine
Code names
FEMA NO. 4223 · NSC-166511
Brand names
  • Amversio
  • Cystadane
  • EnBrace HR
  • EnLyte

Resolves to

Structure
InChIKeyKWIUHFFTVRNATP-UHFFFAOYSA-NSMILESC[N+](C)(C)CC([O-])=O
Targets
Transporters

What you can answer from here — as of September 23, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
1TransporterSubstrate / inhibitor direction, not just membership
Listed above
295Drug interactionsStructured to mechanism, not free text
Sign in
21Clinical trialsPhase, status and sponsor resolved per trial
Sign in
4Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
1ContraindicationEach with its own population and attribute set
Sign in
58Marketed productsAcross 7 countries and 40 labellers
Sign in
2ATC codesIncluding every combination product, plus 15 drug categories
Sign in
15+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Betaine, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account